Your browser doesn't support javascript.
loading
S100A14: A novel negative regulator of cancer stemness and immune evasion by inhibiting STAT3-mediated programmed death-ligand 1 expression in colorectal cancer.
Min, Hye-Young; Cho, Jaebeom; Sim, Jeong Yeon; Boo, Hye-Jin; Lee, Ji-Sun; Lee, Seon-Boon; Lee, Young-Jin; Kim, Sung Joo; Kim, Kyu-Pyo; Park, In-Ja; Hong, Seung-Mo; Zhang, Xue-Li; Zhang, Zhi-Gang; Park, Rang-Woon; Lee, Ho-Young.
Affiliation
  • Min HY; Creative Research Initiative Center for Concurrent Control of Emphysema and Lung Cancer, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Cho J; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
  • Sim JY; Creative Research Initiative Center for Concurrent Control of Emphysema and Lung Cancer, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Boo HJ; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
  • Lee JS; Creative Research Initiative Center for Concurrent Control of Emphysema and Lung Cancer, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Lee SB; Creative Research Initiative Center for Concurrent Control of Emphysema and Lung Cancer, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Lee YJ; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
  • Kim SJ; Creative Research Initiative Center for Concurrent Control of Emphysema and Lung Cancer, College of Pharmacy, Seoul National University, Seoul, Republic of Korea.
  • Kim KP; Department of Biochemistry and Cell Biology, School of Medicine, Cell & Matrix Research Institute, Kyungpook National University, Daegu, Republic of Korea.
  • Park IJ; Department of Biochemistry and Cell Biology, School of Medicine, Cell & Matrix Research Institute, Kyungpook National University, Daegu, Republic of Korea.
  • Hong SM; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Zhang XL; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Zhang ZG; Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Park RW; Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Lee HY; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, P.R. China.
Clin Transl Med ; 12(7): e986, 2022 07.
Article in En | MEDLINE | ID: mdl-35858011

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / STAT3 Transcription Factor Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Transl Med Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / STAT3 Transcription Factor Type of study: Prognostic_studies Limits: Humans Language: En Journal: Clin Transl Med Year: 2022 Document type: Article